5-240451-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004168.4(SDHA):c.1526C>T(p.Ser509Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,456,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S509S) has been classified as Likely benign.
Frequency
Consequence
NM_004168.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHA | NM_004168.4 | c.1526C>T | p.Ser509Leu | missense_variant | 11/15 | ENST00000264932.11 | NP_004159.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHA | ENST00000264932.11 | c.1526C>T | p.Ser509Leu | missense_variant | 11/15 | 1 | NM_004168.4 | ENSP00000264932.6 | ||
ENSG00000286001 | ENST00000651543.1 | n.*259C>T | non_coding_transcript_exon_variant | 10/24 | ENSP00000499215.1 | |||||
ENSG00000286001 | ENST00000651543.1 | n.*259C>T | 3_prime_UTR_variant | 10/24 | ENSP00000499215.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1456718Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 724874
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial complex II deficiency, nuclear type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2012 | - - |
Paragangliomas 5;C5700310:Mitochondrial complex II deficiency, nuclear type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 08, 2022 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 509 of the SDHA protein (p.Ser509Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with leukodystrophy, cardiomyopathy and mitochondrial complex II deficiency (PMID: 22972948, 26642834). ClinVar contains an entry for this variant (Variation ID: 39586). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SDHA protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on SDHA function (PMID: 22972948). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 31, 2024 | The p.S509L variant (also known as c.1526C>T), located in coding exon 11 of the SDHA gene, results from a C to T substitution at nucleotide position 1526. The serine at codon 509 is replaced by leucine, an amino acid with dissimilar properties. This variant has been previously identified in conjunction with another SDHA missense variant in a patient with severe isolated complex II deficiency; the two alterations were confirmed to be in trans based on parental testing. However, control allele frequencies were not reported in this study (Alston CL et al. J Med Genet, 2012 Sep;49:569-77). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at